BDNF isoforms: a round trip ticket between neurogenesis and serotonin?

Journal of Neurochemistry

Volumn , Issue , 2016, Pages 204-221

  Foltran, Rocío Beatriz ^a   Diaz, Silvina Laura ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

adult hippocampal neurogenesis; BDNF isoforms; rodents; serotonergic system; SSRI antidepressants

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CITALOPRAM; DESIPRAMINE; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

BDNF GENE; DENTATE GYRUS; GABAERGIC SYSTEM; GENE EXPRESSION; GENE STRUCTURE; HIPPOCAMPUS; HUMAN; IN SITU HYBRIDIZATION; INTERNEURON; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MAJOR DEPRESSION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SUICIDE; WESTERN BLOTTING;

EID: 84979021698     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13658     Document Type: Review

References (192)

1. Adachi M., Barrot M., Autry A. E., Theobald D. and Monteggia L. M. (2008) Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 63, 642–649.
2. Aid T., Kazantseva A., Piirsoo M., Palm K. and Timmusk T. (2007) Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525–535.
3. Aloyz R., Fawcett J. P., Kaplan D. R., Murphy R. A. and Miller F. D. (1999) Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS. Learn. Mem. 6, 216–231.
4. Altman J. and Das G. D. (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 124, 319–335.
5. An J. J., Gharami K., Liao G. Y. et al. (2008) Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134, 175–187.
6. Anastasia A., Deinhardt K., Chao M. V., Will N. E., Irmady K., Lee F. S., Hempstead B. L. and Bracken C. (2013) Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat. Commun. 4, 2490.
7. Avila M. A., Varela-Nieto I., Romero G., Mato J. M., Giraldez F., Van De Water T. R. and Represa J. (1993) Brain-derived neurotrophic factor and neurotrophin-3 support the survival and neuritogenesis response of developing cochleovestibular ganglion neurons. Dev. Biol. 159, 266–275.
8. Bamji S. X., Majdan M., Pozniak C. D., Belliveau D. J., Aloyz R., Kohn J., Causing C. G. and Miller F. D. (1998) The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140, 911–923.
9. Banasr M., Hery M., Printemps R. and Daszuta A. (2004) Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 29, 450–460.
10. Barde Y. A., Edgar D. and Thoenen H. (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1, 549–553.
11. NTR: a study in contrasts. Cell Death Differ. 5, 346–356.
12. Barker P. A. (2004) p75NTR is positively promiscuous: novel partners and new insights. Neuron 42, 529–533.
13. Bath K. G. and Lee F. S. (2006) Variant BDNF (Val66Met) impact on brain structure and function. Cogn. Affect. Behav. Neurosci. 6, 79–85.
14. Baxter G. T., Radeke M. J., Kuo R. C. et al. (1997) Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2. J. Neurosci. 17, 2683–2690.
15. Bekinschtein P., Cammarota M. and Medina J. H. (2014) BDNF and memory processing. Neuropharmacology 76C, 677–683.
16. Bibel M. and Barde Y. A. (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14, 2919–2937.
17. Brezun J. M. and Daszuta A. (1999) Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 89, 999–1002.
18. Brunoni A. R., Lopes M. and Fregni F. (2008) A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11, 1169–1180.
19. Calabrese F., Molteni R., Maj P. F., Cattaneo A., Gennarelli M., Racagni G. and Riva M. A. (2007) Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32, 2351–2359.
20. Cao W., Duan J., Wang X. et al. (2014) Early enriched environment induces an increased conversion of proBDNF to BDNF in the adult rat's hippocampus. Behav. Brain Res. 265, 76–83.
21. Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. T. and Chao M. V. (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716–719.
22. Casaccia-Bonnefil P., Kong H. and Chao M. V. (1998) Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ. 5, 357–364.
23. Castrén E. and Rantamäki T. (2010) Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs 24, 1–7.
24. Chao M. V. (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299–309.
25. Chao M. and Hempstead B. (1995) p75 and Trk: a two-receptor system. Trends Neurosci. 18, 321–326.
26. Cheema S. S., Barrett G. L. and Bartlett P. F. (1996) Reducing p75 nerve growth factor receptor levels using antisense oligonucleotides prevents the loss of axotomized sensory neurons in the dorsal root ganglia of newborn rats. J. Neurosci. Res. 46, 239–245.
27. Chen B., Dowlatshahi D., MacQueen G. M., Wang J. F. and Young L. T. (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260–265.
28. Chen Z. Y., Patel P. D., Sant G., Meng C. X., Teng K. K., Hempstead B. L. and Lee F. S. (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24, 4401–4411.
29. Chen Z. Y., Ieraci A., Teng H., Dall H., Meng C. X., Herrera D. G., Nykjaer A., Hempstead B. L. and Lee F. S. (2005) Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J. Neurosci. 25, 6156–6166.
30. Chen M. J., Nguyen T. V., Pike C. J. and Russo-Neustadt A. A. (2007) Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell. Signal. 19, 114–128.
31. Cheng A., Coksaygan T., Tang H., Khatri R., Balice-Gordon R. J., Rao M. S. and Mattson M. P. (2007) Truncated tyrosine kinase B brain-derived neurotrophic factor receptor directs cortical neural stem cells to a glial cell fate by a novel signaling mechanism. J. Neurochem. 100, 1515–1530.
32. Climent E., Sancho-Tello M., Miñana R., Barettino D. and Guerri C. (2000) Astrocytes in culture express the full-length Trk-B receptor and respond to brain derived neurotrophic factor by changing intracellular calcium levels: effect of ethanol exposure in rats. Neurosci. Lett. 288, 53–56.
33. Cohen S., Levi-Montalcini R. and Hamburger V. (1954) A nerve growth-stimulating factor isolated from sarcom as 37 and 180. Proc. Natl Acad. Sci. USA 40, 1014–1018.
34. Cosgaya J. M., Chan J. R. and Shooter E. M. (2002) The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 298, 1245–1248.
35. Costa M. S., Ardais A. P., Fioreze G. T., Mioranzza S., Botton P. H., Souza D. O., Rocha J. B. and Porciúncula L. O. (2012) The impact of the frequency of moderate exercise on memory and brain-derived neurotrophic factor signaling in young adult and middle-aged rats. Neuroscience 222, 100–109.
36. Dekeyne A., Mannoury la Cour C., Gobert A. et al. (2008) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology 199, 549–568.
37. Deltheil T., Guiard B. P., Guilloux J. P. et al. (2008) Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus. Pharmacol. Biochem. Behav. 90, 174–183.
38. Di Lieto A., Rantamäki T., Vesa L., Yanpallewar S., Antila H., Lindholm J., Rios M., Tessarollo L. and Castrén E. (2012) The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse development. PLoS ONE 7, e32869.
39. Diaz S. L. and Maroteaux L. (2011) Implication of 5-HT(2B) receptors in the serotonin syndrome. Neuropharmacology 61, 495–502.
40. Diaz S. L., Doly S., Narboux-Nême N. et al. (2012) 5-HT(2B) receptors are required for serotonin-selective antidepressant actions. Mol. Psychiatry 17, 154–163.
41. Diaz S. L., Narboux-Nême N., Trowbridge S. et al. (2013) Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin. Eur. J. Neurosci. 38, 2650–2658.
42. Diaz S. L., Narboux-Nême N., Boutourlinsky K., Doly S. and Maroteaux L. (2016) Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants. Eur. Neuropsychopharmacol. 26, 265–279.
43. Dieni S., Matsumoto T., Dekkers M. et al. (2012) BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. J. Cell Biol. 196, 775–788.
44. Ding Q., Ying Z. and Gómez-Pinilla F. (2011) Exercise influences hippocampal plasticity by modulating brain-derived neurotrophic factor processing. Neuroscience 192, 773–780.
45. Domínguez-Escribà L., Hernández-Rabaza V., Soriano-Navarro M., Barcia J. A., Romero F. J., García-Verdugo J. M. and Canales J. J. (2006) Chronic cocaine exposure impairs progenitor proliferation but spares survival and maturation of neural precursors in adult rat dentate gyrus. Eur. J. Neurosci. 24, 586–594.
46. Duman R. S. (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 5, 11–25.
47. Dwivedi Y., Rizavi H. S., Conley R. R., Roberts R. C., Tamminga C. A. and Pandey G. N. (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60, 804–815.
48. Ebendal T. (1992) Function and evolution in the NGF family and its receptors. J. Neurosci. Res. 32, 461–470.
49. Egan M. F., Kojima M., Callicott J. H. et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269.
50. Eide F. F., Vining E. R., Eide B. L., Zang K., Wang X. Y. and Reichardt L. F. (1996) Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci. 16, 3123–3129.
51. Eisch A. J., Barrot M., Schad C. A., Self D. W. and Nestler E. J. (2000) Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl Acad. Sci. USA 97, 7579–7584.
52. Encinas J. M., Vaahtokari A. and Enikolopov G. (2006) Fluoxetine targets early progenitor cells in the adult brain. Proc. Natl Acad. Sci. USA 103, 8233–8238.
53. Ernfors P., Lee K. F. and Jaenisch R. (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368, 147–150.
54. Ethell I. M. and Ethell D. W. (2007) Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J. Neurosci. Res. 85, 2813–2823.
55. Farhadi H. F., Mowla S. J., Petrecca K., Morris S. J., Seidah N. G. and Murphy R. A. (2000) Neurotrophin-3 sorts to the constitutive secretory pathway of hippocampal neurons and is diverted to the regulated secretory pathway by coexpression with brain-derived neurotrophic factor. J. Neurosci. 20, 4059–4068.
56. Fenner B. (2012) Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev. 23, 15–24.
57. de Foubert G., Khundakar A. A. and Zetterström T. S. (2013) Effects of repeated 5-HT₆ receptor stimulation on BDNF gene expression and cell survival. Neurosci. Lett. 553, 211–215.
58. Frisén J., Verge V. M., Fried K., Risling M., Persson H., Trotter J., Hökfelt T. and Lindholm D. (1993) Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems. Proc. Natl Acad. Sci. USA 90, 4971–4975.
59. Fujimura H., Altar C. A., Chen R., Nakamura T., Nakahashi T., Kambayashi J., Sun B. and Tandon N. N. (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb. Haemost. 87, 728–734.
60. Gage F. H. (2000) Mammalian neural stem cells. Science 287, 1433–1438.
61. Gardier A. M., Guiard B. P., Guilloux J. P., Repérant C., Coudoré F. and David D. J. (2009) Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review. Fundam. Clin. Pharmacol. 23, 23–42.
62. Gehler S., Gallo G., Veien E. and Letourneau P. C. (2004) p75 neurotrophin receptor signaling regulates growth cone filopodial dynamics through modulating RhoA activity. J. Neurosci. 24, 4363–4372.
63. Gould E. (1999) Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 21, 46S–51S.
64. Gould E. and Tanapat P. (1999) Stress and hippocampal neurogenesis. Biol. Psychiatry 46, 1472–1479.
65. Gould E., Cameron H. A., Daniels D. C., Woolley C. S. and McEwen B. S. (1992) Adrenal hormones suppress cell division in the adult rat dentate gyrus. J. Neurosci. 12, 3642–3650.
66. Griesbach G. S., Hovda D. A. and Gomez-Pinilla F. (2009) Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation. Brain Res. 1288, 105–115.
67. Guiard B. P., David D. J., Deltheil T. et al. (2008) Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Int. J. Neuropsychopharmacol. 11, 79–92.
68. Haapasalo A., Sipola I., Larsson K., Akerman K. E., Stoilov P., Stamm S., Wong G. and Castren E. (2002) Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms. J. Biol. Chem. 277, 43160–43167.
69. Hamburger V. and Levi-Montalcini R. (1949) Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J. Exp. Zool. 111, 457–501.
70. Hariri A. R., Goldberg T. E., Mattay V. S., Kolachana B. S., Callicott J. H., Egan M. F. and Weinberger D. R. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23, 6690–6694.
71. Harrington A. W., Leiner B., Blechschmitt C. et al. (2004) Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl Acad. Sci. USA 101, 6226–6230.
72. Hartmann D., Drummond J., Handberg E., Ewell S. and Pozzo-Miller L. (2012) Multiple approaches to investigate the transport and activity-dependent release of BDNF and their application in neurogenetic disorders. Neural. Plast. 2012, 203734.
73. Hashimoto K. (2007) BDNF variant linked to anxiety-related behaviors. BioEssays 29, 116–119.
74. Hashimoto K. (2010) Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin. Neurosci. 64, 341–357.
75. Hempstead B. L. (2015) Brain-derived neurotrophic factor: three ligands, many actions. Trans. Am. Clin. Climatol. Assoc. 126, 9–19.
76. Hill R. A., Murray S. S., Halley P. G., Binder M. D., Martin S. J. and van den Buuse M. (2011) Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice. Hippocampus 21, 434–445.
77. Horch H. W. and Katz L. C. (2002) BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci. 5, 1177–1184.
78. Huang Y. and Morozov A. (2011) Hippocampal deletion of BDNF gene attenuates gamma oscillations in area CA1 by up-regulating 5-HT3 receptor. PLoS ONE 6, e16480.
79. Huang E. J. and Reichardt L. F. (2001) Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677–736.
80. Hwang J. J., Park M. H., Choi S. Y. and Koh J. Y. (2005) Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases. J. Biol. Chem. 280, 11995–12001.
81. Ignácio Z. M., Réus G. Z., Abelaira H. M. and Quevedo J. (2014) Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: insights in depression. Neuroscience 275, 455–468.
82. Imoto Y., Kira T., Sukeno M., Nishitani N., Nagayasu K., Nakagawa T., Kaneko S., Kobayashi K. and Segi-Nishida E. (2015) Role of the 5-HT4 receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus. Mol. Brain 8, 29.
83. Jha S., Rajendran R., Davda J. and Vaidya V. A. (2006) Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine. Brain Res. 1075, 48–59.
84. Kaplan D. R. and Miller F. D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381–391.
85. Karege F., Schwald M. and Cisse M. (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328, 261–264.
86. Katoh-Semba R., Asano T., Ueda H., Morishita R., Takeuchi I. K., Inaguma Y. and Kato K. (2002) Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J. 16, 1328–1330.
87. Kempermann G., Kuhn H. G. and Gage F. H. (1997) More hippocampal neurons in adult mice living in an enriched environment. Nature 386, 493–495.
88. Kempermann G., Gast D., Kronenberg G., Yamaguchi M. and Gage F. H. (2003) Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 130, 391–399.
89. Kempermann G., Song H. and Gage F. H. (2015) Neurogenesis in the Adult Hippocampus. Cold Spring Harb. Perspect. Biol. 7, a018812.
90. Klein R., Conway D., Parada L. F. and Barbacid M. (1990) The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 61, 647–656.
91. Klempin F., Babu H., De Pietri Tonelli D., Alarcon E., Fabel K. and Kempermann G. (2010) Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Front. Mol. Neurosci. 3, 14.
92. Klempin F., Beis D., Mosienko V., Kempermann G., Bader M. and Alenina N. (2013) Serotonin is required for exercise-induced adult hippocampal neurogenesis. J. Neurosci. 33, 8270–8275.
93. Kohara K., Kitamura A., Morishima M. and Tsumoto T. (2001) Activity-depen dent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291, 2419–2423.
94. Korte M., Carroll P., Wolf E., Brem G., Thoenen H. and Bonhoeffer T. (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl Acad. Sci. USA 92, 8856–8860.
95. Kronenberg G., Mosienko V., Gertz K., Alenina N., Hellweg R. and Klempin F. (2016) Increased brain-derived neurotrophic factor (BDNF) protein concentrations in mice lacking brain serotonin. Eur. Arch. Psychiatry Clin. Neurosci. 266, 281–284.
96. Kruk J. S., Vasefi M. S., Heikkila J. J. and Beazely M. A. (2013) Reactive oxygen species are required for 5-HT-induced transactivation of neuronal platelet-derived growth factor and TrkB receptors, but not for ERK1/2 activation. PLoS ONE 8, e77027.
97. Kuhn H. G., Dickinson-Anson H. and Gage F. H. (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16, 2027–2033.
98. Larsen M. H., Rosenbrock H., Sams-Dodd F. and Mikkelsen J. D. (2007) Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine. Eur. J. Pharmacol. 555, 115–121.
99. Larsen M. H., Mikkelsen J. D., Hay-Schmidt A. and Sandi C. (2010) Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J. Psychiatr. Res. 44, 808–816.
100. Lau A. G., Irier H. A., Gu J. et al. (2010) Distinct 3′UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc. Natl Acad. Sci. USA 107, 15945–15950.
101. Lee F. S. and Chao M. V. (2001) Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl Acad. Sci. USA 98, 3555–3560.
102. Lee R., Kermani P., Teng K. K. and Hempstead B. L. (2001) Regulation of cell survival by secreted proneurotrophins. Science 294, 1945–1948.
103. Lee F. S., Rajagopal R., Kim A. H., Chang P. C. and Chao M. V. (2002a) Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J. Biol. Chem. 277, 9096–9102.
104. Lee J., Duan W. and Mattson M. P. (2002b) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 82, 1367–1375.
105. Lefebvre P. P., Malgrange B., Staecker H., Moghadass M., Van de Water T. R. and Moonen G. (1994) Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. NeuroReport 5, 865–868.
106. Lessmann V. and Brigadski T. (2009) Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update. Neurosci. Res. 65, 11–22.
107. Levi-Montalcini R. (1966) The nerve growth factor: its mode of action on sensory and sympathetic nerve cells. Harvey Lect. 60, 217–259.
108. Li Y., Luikart B. W., Birnbaum S., Chen J., Kwon C. H., Kernie S. G., Bassel-Duby R. and Parada L. F. (2008) TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59, 399–412.
109. Liu Q. R., Walther D., Drgon T. et al. (2005) Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B, 93–103.
110. Lochner J. E., Spangler E., Chavarha M., Jacobs C., McAllister K., Schuttner L. C. and Scalettar B. A. (2008) Efficient copackaging and cotransport yields postsynaptic colocalization of neuromodulators associated with synaptic plasticity. Dev. Neurobiol. 68, 1243–1256.
111. Lom B. and Cohen-Cory S. (1999) Brain-derived neurotrophic factor differentially regulates retinal ganglion cell dendritic and axonal arborization in vivo. J. Neurosci. 19, 9928–9938.
112. Lu B. (2003) Pro-region of neurotrophins: role in synaptic modulation. Neuron 39, 735–738.
113. Lu B., Pang P. T. and Woo N. H. (2005) The yin and yang of neurotrophin action. Nat. Rev. Neurosci. 6, 603–614.
114. Lucas G., Rymar V. V., Du J. et al. (2007) Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55, 712–725.
115. Luttrell L. M., Daaka Y. and Lefkowitz R. J. (1999) Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11, 177–183.
116. Malberg J. E., Eisch A. J., Nestler E. J. and Duman R. S. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104–9110.
117. Martínez-Levy G. A. and Cruz-Fuentes C. S. (2014) Genetic and epigenetic regulation of the brain-derived neurotrophic factor in the central nervous system. Yale J. Biol. Med. 87, 173–186.
118. Martínez-Murillo R., Caro L. and Nieto-Sampedro M. (1993) Lesion-induced expression of low-affinity nerve growth factor receptor-immunoreactive protein in Purkinje cells of the adult rat. Neuroscience 52, 587–593.
119. Martinowich K., Manji H. and Lu B. (2007) New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10, 1089–1093.
120. McAllister A. K., Lo D. C. and Katz L. C. (1995) Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15, 791–803.
121. McEwen B. S. (1999) Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105–122.
122. Mendez-David I., David D. J., Darcet F., Wu M. V., Kerdine-Römer S., Gardier A. M. and Hen R. (2014) Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism. Neuropsychopharmacology 39, 1366–1378.
123. Middlemas D. S., Lindberg R. A. and Hunter T. (1991) TrkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol. Cell. Biol. 11, 143–153.
124. Migliarini S., Pacini G., Pelosi B., Lunardi G. and Pasqualetti M. (2013) Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol. Psychiatry 18, 1106–1118.
125. Minichiello L., Calella A. M., Medina D. L., Bonhoeffer T., Klein R. and Korte M. (2002) Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 36, 121–137.
126. Mizoguchi H., Nakade J., Tachibana M. et al. (2011) Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus. J. Neurosci. 31, 12963–12971.
127. Molteni R., Calabrese F., Cattaneo A., Mancini M., Gennarelli M., Racagni G. and Riva M. A. (2009) Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 34, 1523–1532.
128. Monteggia L. M., Barrot M., Powell C. M. et al. (2004) Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl Acad. Sci. USA 101, 10827–10832.
129. Mowla S. J., Pareek S., Farhadi H. F., Petrecca K., Fawcett J. P., Seidah N. G., Morris S. J., Sossin W. S. and Murphy R. A. (1999) Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J. Neurosci. 19, 2069–2080.
130. Mowla S. J., Farhadi H. F., Pareek S., Atwal J. K., Morris S. J., Seidah N. G. and Murphy R. A. (2001) Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 276, 12660–12666.
131. Musazzi L., Cattaneo A., Tardito D., Barbon A., Gennarelli M., Barlati S., Racagni G. and Popoli M. (2009) Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants. BMC Neurosci. 10, 48.
132. Musumeci G. and Minichiello L. (2011) BDNF-TrkB signalling in fear learning: from genetics to neural networks. Rev. Neurosci. 22, 303–315.
133. Nagappan G. and Lu B. (2005) Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci. 28, 464–471.
134. Nagappan G., Zaitsev E., Senatorov V. V., Jr, Yang J., Hempstead B. L. and Lu B. (2009) Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc. Natl Acad. Sci. USA 106, 1267–1272.
135. Nibuya M., Morinobu S. and Duman R. S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539–7547.
136. Niitsu T., Shirayama Y., Matsuzawa D., Shimizu E., Hashimoto K. and Iyo M. (2014) Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia. Neurosci. Lett. 575, 37–41.
137. Nixon K. and Crews F. T. (2002) Binge ethanol exposure decreases neurogenesis in adult rat hippocampus. J. Neurochem. 83, 1087–1093.
138. Notaras M., Hill R. and van den Buuse M. (2015) A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review. Neurosci. Biobehav. Rev. 51, 15–30.
139. Nykjaer A., Lee R., Teng K. K. et al. (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843–848.
140. Pang P. T., Teng H. K., Zaitsev E. et al. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487–491.
141. Patterson S. L., Abel T., Deuel T. A., Martin K. C., Rose J. C. and Kandel E. R. (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16, 1137–1145.
142. Petrik D., Lagace D. C. and Eisch A. J. (2012) The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology 62, 21–34.
143. Popa D., Cerdan J., Repérant C., Guiard B. P., Guilloux J. P., David D. J. and Gardier A. M. (2010) A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. Eur. J. Pharmacol. 628, 83–90.
144. van Praag H., Christie B. R., Sejnowski T. J. and Gage F. H. (1999) Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl Acad. Sci. USA 96, 13427–13431.
145. Rabacchi S. A., Kruk B., Hamilton J., Carney C., Hoffman J. R., Meyer S. L., Springer J. E. and Baird D. H. (1999) BDNF and NT4/5 promote survival and neurite outgrowth of pontocerebellar mossy fiber neurons. J. Neurobiol. 40, 254–269.
146. Rabizadeh S., Oh J., Zhong L. T., Yang J., Bitler C. M., Butcher L. L. and Bredesen D. E. (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261, 345–348.
147. Rantamäki T., Hendolin P., Kankaanpää A., Mijatovic J., Piepponen P., Domenici E., Chao M. V., Männistö P. T. and Castrén E. (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32, 2152–2162.
148. Reichardt L. F. (2006) Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1545–1564.
149. Réus G. Z., Vieira F. G., Abelaira H. M. et al. (2014) MAPK signaling correlates with the antidepressant effects of ketamine. J. Psychiatr. Res. 55, 15–21.
150. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R. M. and Jaenisch R. (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 10, 1748–1757.
151. Rodriguez-Tébar A. and Barde Y. A. (1988) Binding characteristics of brain-derived neurotrophic factor to its receptors on neurons from the chick embryo. J. Neurosci. 8, 3337–3342.
152. Rossi C., Angelucci A., Costantin L. et al. (2006) Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur. J. Neurosci. 24, 1850–1856.
153. Roux P. P., Colicos M. A., Barker P. A. and Kennedy T. E. (1999) p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. J. Neurosci. 19, 6887–6896.
154. Rudge J. S., Li Y., Pasnikowski E. M., Mattsson K., Pan L., Yancopoulos G. D., Wiegand S. J., Lindsay R. M. and Ip N. Y. (1994) Neurotrophic factor receptors and their signal transduction capabilities in rat astrocytes. Eur. J. Neurosci. 6, 693–705.
155. Russo-Neustadt A., Beard R. C. and Cotman C. W. (1999) Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21, 679–682.
156. Saarelainen T., Hendolin P., Lucas G. et al. (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23, 349–357.
157. Sachs B. D., Jacobsen J. P., Thomas T. L., Siesser W. B., Roberts W. L. and Caron M. G. (2013) The effects of congenital brain serotonin deficiency on responses to chronic fluoxetine. Transl. Psychiatry 3, e291.
158. Sairanen M., Lucas G., Ernfors P., Castrén M. and Castrén E. (2005) Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 25, 1089–1094.
159. Santarelli L., Saxe M., Gross C. et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805–809.
160. Sarkisyan G. and Hedlund P. B. (2009) The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav. Brain Res. 202, 26–31.
161. Sartori C. R., Vieira A. S., Ferrari E. M., Langone F., Tongiorgi E. and Parada C. A. (2011) The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA. Neuroscience 180, 9–18.
162. Segawa M., Morinobu S., Matsumoto T., Fuchikami M. and Yamawaki S. (2013) Electroconvulsive seizure, but not imipramine, rapidly up-regulates pro-BDNF and t-PA, leading to mature BDNF production, in the rat hippocampus. Int. J. Neuropsychopharmacol. 16, 339–350.
163. Seidah N. G., Benjannet S., Pareek S. et al. (1996) Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem. J. 314, 951–960.
164. Sen S., Duman R. and Sanacora G. (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 64, 527–532.
165. Shi Y., You J., Yuan Y., Zhang X., Li H. and Hou G. (2010) Plasma BDNF and tPA are associated with late-onset geriatric depression. Psychiatry Clin. Neurosci. 64, 249–254.
166. Shirayama Y., Chen A. C., Nakagawa S., Russell D. S. and Duman R. S. (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251–3261.
167. Snyder J. S., Choe J. S., Clifford M. A., Jeurling S. I., Hurley P., Brown A., Kamhi J. F. and Cameron H. A. (2009) Adult-born hippocampal neurons are more numerous, faster maturing, and more involved in behavior in rats than in mice. J. Neurosci. 29, 14484–14495.
168. Song J., Zhong C., Bonaguidi M. A. et al. (2012) Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision. Nature 489, 150–154.
169. Stoilov P., Castren E. and Stamm S. (2002) Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochem. Biophys. Res. Commun. 290, 1054–1065.
170. Suzuki S., Numakawa T., Shimazu K., Koshimizu H., Hara T., Hatanaka H., Mei L., Lu B. and Kojima M. (2004) BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. J. Cell Biol. 167, 1205–1215.
171. Swift J. L., Godin A. G., Doré K. et al. (2011) Quantification of receptor tyrosine kinase transactivation through direct dimerization and surface density measurements in single cells. Proc. Natl Acad. Sci. USA 108, 7016–7021.
172. Tanaka S., Sekino Y. and Shirao T. (2000) The effects of neurotrophin-3 and brain-derived neurotrophic factor on cerebellar granule cell movement and neurite extension in vitro. Neuroscience 97, 727–734.
173. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G. and Popoli M. (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev. 58, 115–134.
174. Teng H. K., Teng K. K., Lee R. et al. (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 25, 5455–5463.
175. Tongiorgi E., Sartori A., Baj G., Bratina A., Di Cola F., Zorzon M. and Pizzolato G. (2012) Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis. J. Neurol. Sci. 320, 161–165.
176. Tsirka S. E., Rogove A. D., Bugge T. H., Degen J. L. and Strickland S. (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17, 543–552.
177. Tucker K. L., Meyer M. and Barde Y. A. (2001) Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4, 29–37.
178. Ueda S., Sakakibara S. and Yoshimoto K. (2005) Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learning. Neuroscience 135, 395–402.
179. Vafadari B., Salamian A. and Kaczmarek L. (2016) MMP-9 in Translation: from Molecule to Brain Physiology, Pathology and Therapy. J. Neurochem. doi: 10.1111/jnc.13415.
180. Wang J. W., Dranovsky A. and Hen R. (2008) The when and where of BDNF and the antidepressant response. Biol. Psychiatry 63, 640–641.
181. Waterhouse E. G., An J. J., Orefice L. L., Baydyuk M., Liao G. Y., Zheng K., Lu B. and Xu B. (2012) BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission. J. Neurosci. 32, 14318–14330.
182. Woo N. H., Teng H. K., Siao C. J., Chiaruttini C., Pang P. T., Milner T. A., Hempstead B. L. and Lu B. (2005) Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 8, 1069–1077.
183. Wu Y. C., Hill R. A., Klug M. and van den Buuse M. (2012) Sex-specific and region-specific changes in BDNF-TrkB signalling in the hippocampus of 5-HT1A receptor and BDNF single and double mutant mice. Brain Res. 1452, 10–17.
184. Wyneken U., Sandoval M., Sandoval S., Jorquera F., González I., Vargas F., Falcon R., Monari M. and Orrego F. (2006) Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses. Neuropsychopharmacology 31, 2415–2423.
185. Yamashita T., Tucker K. L. and Barde Y. A. (1999) Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24, 585–593.
186. Yang J., Harte-Hargrove L., Siao C. J. et al. (2014) proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep. 7, 796–806.
187. Yeh C. M., Huang C. C. and Hsu K. S. (2012) Prenatal stress alters hippocampal synaptic plasticity in young rat offspring through preventing the proteolytic conversion of pro-brain-derived neurotrophic factor (BDNF) to mature BDNF. J. Physiol. 590, 991–1010.
188. Yoshida T., Ishikawa M., Niitsu T. et al. (2012) Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS ONE 7, e42676.
189. Yoshimura R., Kishi T., Hori H., Atake K., Katsuki A., Nakano-Umene W., Ikenouchi-Sugita A., Iwata N. and Nakamura J. (2014) Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients. Ann. Gen. Psychiatry 13, 19.
190. Zheng L., Fisher G., Miller R. E., Peschon J., Lynch D. H. and Lenardo M. J. (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348–351.
191. Zhou X. F., Song X. Y., Zhong J. H., Barati S., Zhou F. H. and Johnson S. M. (2004) Distribution and localization of pro-brain-derived neurotrophic factor-like immunoreactivity in the peripheral and central nervous system of the adult rat. J. Neurochem. 91, 704–715.
192. Zhou L., Xiong J., Lim Y., Ruan Y., Huang C., Zhu Y., Zhong J. H., Xiao Z. and Zhou X. F. (2013) Upregulation of blood proBDNF and its receptors in major depression. J. Affect. Disord. 150, 776–784.